Madison, Wisconsin-based biotechnology company developing genetic-based therapeutics for chronic conditions, including obesity, cardiometabolic, age-related, and inflammatory diseases
Madison, Wisconsin-based biotechnology company developing genetic-based therapeutics for chronic conditions, including obesity, cardiometabolic, age-related, and inflammatory diseases. It has also pursued a COVID-19 vaccine approach using a SARS protein to train T cells to target infected cells.